Oral psoriasis.
D000284:Administration, Oral; D002175:Candida / Q000302:isolation & purification; D002180:Candidiasis, Oral / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D002908:Chronic Disease; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000150:complications*; D009061:Mouth Mucosa / Q000473:pathology; D009067:Mouthwashes; D009761:Nystatin / Q000008:administration & dosage / Q000627:therapeutic use; D009824:Ointments; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D012008:Recurrence; D013444:Sulfisoxazole / Q000009:adverse effects
D009067:Mouthwashes; D009824:Ointments; D005446:Fluocinolone Acetonide; D009761:Nystatin; D013444:Sulfisoxazole